BRCA1 and ovarian cancer: Data from several international studies suggest that patients with a loss of heterozygosity of the BRCA1 and BRCA2 genes, which are located on 17q21 and found in hereditary forms of breast cancer, have a 6–61-fold increased lifetime risk of ovarian cancer compared with general population rates (Antoniou et al, 2003).